Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1038/s41577-021-00516-z http://scihub22266oqcxt.onion/10.1038/s41577-021-00516-z 33623123!7901163!33623123     free     free     free Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Nat+Rev+Immunol 2021 ; 21 (4): 202-203 Nephropedia Template TP {{tp|p=33623123|t=2021. SARS-CoV-2 infection and COVID-19 in asthmatics: a complex relationship |pdf=|usr=}}{{33623123}} gab.com Text SARS-CoV-2 infection and COVID-19 in asthmatics: a complex relationship JO: Nat Rev Immunol http://www.kidney.de/pget.php?&tw=1&pmid=33623123 #FOAvip Risk of severe coronavirus disease 2019 (COVID-19) after infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is increased in patients with certain comorbidities, including chronic obstructive pulmonary disease (COPD). By contrast, epidemiological data from many (but not all) countries indicate a low prevalence of asthma among patients with severe COVID-19. This reduced risk of severe COVID-19 may apply specifically to patients with the type 2 asthma endotype, which is most common in childhood asthma. Twit Text FOAVip SARS-CoV-2 infection and COVID-19 in asthmatics: a complex relationship ????Nat Rev Immunol http://www.kidney.de/pget.php?&tw=1&pmid=33623123 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33623123 #FOAvip English Wikipedia <ref>{{Cite pmid|33623123}}</ref> SARS-CoV-2 infection and COVID-19 in asthmatics: a complex relationship #MMPMID33623123 Skevaki C; Karsonova A; Karaulov A; Fomina D; Xie M; Chinthrajah S; Nadeau KC; Renz H Nat Rev Immunol 2021[Apr]; 21 (4): 202-203 PMID33623123show ga Risk of severe coronavirus disease 2019 (COVID-19) after infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is increased in patients with certain comorbidities, including chronic obstructive pulmonary disease (COPD). By contrast, epidemiological data from many (but not all) countries indicate a low prevalence of asthma among patients with severe COVID-19. This reduced risk of severe COVID-19 may apply specifically to patients with the type 2 asthma endotype, which is most common in childhood asthma. |Angiotensin-Converting Enzyme 2/genetics/metabolism[MESH] |Asthma/*epidemiology/*immunology[MESH] |COVID-19/*epidemiology[MESH] |Eosinophilia/immunology[MESH] |Humans[MESH] |Interleukin-13/immunology[MESH] |Interleukin-4/immunology[MESH] |Interleukin-5/immunology[MESH] |Phenotype[MESH] |Pulmonary Disease, Chronic Obstructive/epidemiology/immunology[MESH] |RNA, Messenger/metabolism[MESH] |Receptors, Coronavirus/genetics/metabolism[MESH] |Risk[MESH] |SARS-CoV-2[MESH] |Severity of Illness Index[MESH] |Th1 Cells/immunology[MESH] |Th17 Cells/immunology[MESH]SARS-CoV-2 infection and COVID-19 in asthmatics: a complex relationshi(epmc).pdf DeepDyve Pubget Overpricing